Ocular Therapeutix Inc (OCUL)
8.83
+0.31
(+3.64%)
USD |
NASDAQ |
Nov 22, 16:00
8.84
+0.01
(+0.11%)
After-Hours: 20:00
Ocular Therapeutix Market Cap: 1.388B for Nov. 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 22, 2024 | 1.388B |
| November 21, 2024 | 1.339B |
| November 20, 2024 | 1.380B |
| November 19, 2024 | 1.402B |
| November 18, 2024 | 1.366B |
| November 15, 2024 | 1.440B |
| November 14, 2024 | 1.560B |
| November 13, 2024 | 1.667B |
| November 12, 2024 | 1.667B |
| November 11, 2024 | 1.723B |
| November 08, 2024 | 1.739B |
| November 07, 2024 | 1.689B |
| November 06, 2024 | 1.714B |
| November 05, 2024 | 1.656B |
| November 04, 2024 | 1.609B |
| November 01, 2024 | 1.628B |
| October 31, 2024 | 1.650B |
| October 30, 2024 | 1.736B |
| October 29, 2024 | 1.770B |
| October 28, 2024 | 1.781B |
| October 25, 2024 | 1.745B |
| October 24, 2024 | 1.706B |
| October 23, 2024 | 1.701B |
| October 22, 2024 | 1.770B |
| October 21, 2024 | 1.781B |
| Date | Value |
|---|---|
| October 18, 2024 | 1.775B |
| October 17, 2024 | 1.737B |
| October 16, 2024 | 1.797B |
| October 15, 2024 | 1.603B |
| October 14, 2024 | 1.639B |
| October 11, 2024 | 1.532B |
| October 10, 2024 | 1.444B |
| October 09, 2024 | 1.457B |
| October 08, 2024 | 1.460B |
| October 07, 2024 | 1.485B |
| October 04, 2024 | 1.541B |
| October 03, 2024 | 1.446B |
| October 02, 2024 | 1.458B |
| October 01, 2024 | 1.419B |
| September 30, 2024 | 1.363B |
| September 27, 2024 | 1.353B |
| September 26, 2024 | 1.369B |
| September 25, 2024 | 1.378B |
| September 24, 2024 | 1.339B |
| September 23, 2024 | 1.319B |
| September 20, 2024 | 1.400B |
| September 19, 2024 | 1.410B |
| September 18, 2024 | 1.411B |
| September 17, 2024 | 1.366B |
| September 16, 2024 | 1.392B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
152.41M
Minimum
Nov 26 2019
1.797B
Maximum
Oct 16 2024
665.37M
Average
492.31M
Median
Market Cap Benchmarks
| 4D Molecular Therapeutics Inc | 360.11M |
| NovaBay Pharmaceuticals Inc | 3.327M |
| Palatin Technologies Inc | 18.77M |
| iBio Inc | 24.15M |
| Theriva Biologics Inc | 3.562M |
Market Cap Related Metrics
| PS Ratio | 19.94 |
| PEG Ratio | -0.4237 |
| Price to Book Value | 3.944 |
| Price | 8.83 |
| Earnings Yield | -14.95% |
| PEGY Ratio | -0.4237 |